Growing community of inventors

Tappernoeje, Denmark

Leif Noerskov-Lauritsen

Average Co-Inventor Count = 4.61

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 18

Leif Noerskov-LauritsenHenrik Sune Andersen (2 patents)Leif Noerskov-LauritsenCarsten Behrens (2 patents)Leif Noerskov-LauritsenNils Langeland Johansen (2 patents)Leif Noerskov-LauritsenJens Buchardt (1 patent)Leif Noerskov-LauritsenJianhe Chen (1 patent)Leif Noerskov-LauritsenHelle Demuth (1 patent)Leif Noerskov-LauritsenPeter Thygesen (1 patent)Leif Noerskov-LauritsenChristine Brunn Schioedt (1 patent)Leif Noerskov-LauritsenLeif Noerskov-Lauritsen (3 patents)Henrik Sune AndersenHenrik Sune Andersen (63 patents)Carsten BehrensCarsten Behrens (20 patents)Nils Langeland JohansenNils Langeland Johansen (19 patents)Jens BuchardtJens Buchardt (8 patents)Jianhe ChenJianhe Chen (7 patents)Helle DemuthHelle Demuth (4 patents)Peter ThygesenPeter Thygesen (3 patents)Christine Brunn SchioedtChristine Brunn Schioedt (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novo Nordisk Healthcare Ag (3 from 88 patents)


3 patents:

1. 9695226 - Growth hormones with prolonged in-vivo efficacy

2. 9211342 - Stable growth hormone compounds resistant to proteolytic degradation

3. 8779109 - Growth hormones with prolonged in-vivo efficacy

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…